---
figid: PMC6787681__healthcare-07-00094-g004
figtitle: AT-rich interactive domain 1A (ARID1A) chromatin remodeling abnormalities
  in ovarian clear cell carcinoma (OCCC)
organisms:
- NA
pmcid: PMC6787681
filename: healthcare-07-00094-g004.jpg
figlink: /pmc/articles/PMC6787681/figure/healthcare-07-00094-f004/
number: F4
caption: 'AT-rich interactive domain 1A (ARID1A) chromatin remodeling abnormalities
  in ovarian clear cell carcinoma (OCCC). ARID1A (green), a member of the switch/sucrose
  nonfermentable (SWI/SNF) complex (blue), works as a tumor suppressor through chromatin
  remodeling, DNA repair, and Myc inhibition. It also plays a role in the phosphoinositide
  3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway (red). ARID1A
  mutations are characteristic and frequent in OCCC, indicating its potential as an
  effective therapeutic target. Inhibitors of enhancer of zeste homolog 2 (EZH2) and
  bromodomain and extra-terminal domain protein (BET) induced synthetic lethality
  in ARID1A-mutated OCCC tumors via PI3K/AKT signaling (green). CDK1A: cyclin-dependent
  kinase inhibitor 1A.'
papertitle: 'Current Position of the Molecular Therapeutic Targets for Ovarian Clear
  Cell Carcinoma: A Literature Review.'
reftext: Tsukuru Amano, et al. Healthcare (Basel). 2019 Sep;7(3):94.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.954088
figid_alias: PMC6787681__F4
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC6787681__F4
ndex: be603bee-dea1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6787681__healthcare-07-00094-g004.html
  '@type': Dataset
  description: 'AT-rich interactive domain 1A (ARID1A) chromatin remodeling abnormalities
    in ovarian clear cell carcinoma (OCCC). ARID1A (green), a member of the switch/sucrose
    nonfermentable (SWI/SNF) complex (blue), works as a tumor suppressor through chromatin
    remodeling, DNA repair, and Myc inhibition. It also plays a role in the phosphoinositide
    3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway (red). ARID1A
    mutations are characteristic and frequent in OCCC, indicating its potential as
    an effective therapeutic target. Inhibitors of enhancer of zeste homolog 2 (EZH2)
    and bromodomain and extra-terminal domain protein (BET) induced synthetic lethality
    in ARID1A-mutated OCCC tumors via PI3K/AKT signaling (green). CDK1A: cyclin-dependent
    kinase inhibitor 1A.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMARCA1
  - ARID1A
  - EZH2
  - DNER
  - MYC
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CDKN1A
  - CDPF1
  - hfw
  - Iswi
  - snf
  - E(z)
  - bet
  - Myc
  - Mtor
  - Tor
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
---
